SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allscripts Healthcare Solutions, Inc. – ‘10-Q’ for 6/30/18 – ‘ZIP’

On:  Monday, 8/6/18, at 9:18am ET   ·   For:  6/30/18   ·   Accession #:  1564590-18-19295   ·   File #:  1-35547

Previous ‘10-Q’:  ‘10-Q’ on 5/8/18 for 3/31/18   ·   Next:  ‘10-Q’ on 11/2/18 for 9/30/18   ·   Latest:  ‘10-Q’ on 11/7/22 for 9/30/22   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/06/18  Allscripts Healthcare Soluti… Inc 10-Q        6/30/18  106:22M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.36M 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    501K 
                Liquidation or Succession                                        
 3: EX-2.2      Plan of Acquisition, Reorganization, Arrangement,   HTML    524K 
                Liquidation or Succession                                        
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     38K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     33K 
13: R1          Document and Entity Information                     HTML     52K 
14: R2          Consolidated Balance Sheets (Unaudited)             HTML    161K 
15: R3          Consolidated Balance Sheets (Unaudited)             HTML     54K 
                (Parenthetical)                                                  
16: R4          Consolidated Statements of Operations (Unaudited)   HTML    131K 
17: R5          Consolidated Statements of Comprehensive Income     HTML     63K 
                (Loss) (Unaudited)                                               
18: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    127K 
19: R7          Basis of Presentation and Significant Accounting    HTML     49K 
                Policies                                                         
20: R8          Revenue from Contracts with Customers               HTML    611K 
21: R9          Business Combinations                               HTML    172K 
22: R10         Fair Value Measurements and Long-term Investments   HTML    183K 
23: R11         Stockholders' Equity                                HTML    142K 
24: R12         Earnings (Loss) Per Share                           HTML    249K 
25: R13         Goodwill and Intangible Assets                      HTML    262K 
26: R14         Debt                                                HTML    309K 
27: R15         Income Taxes                                        HTML     68K 
28: R16         Derivative Financial Instruments                    HTML    212K 
29: R17         Other Comprehensive Income                          HTML    365K 
30: R18         Contingencies                                       HTML     40K 
31: R19         Discontinued Operations                             HTML    137K 
32: R20         Business Segments                                   HTML    196K 
33: R21         Supplemental Disclosures                            HTML     80K 
34: R22         Subsequent Events                                   HTML     38K 
35: R23         Basis of Presentation and Significant Accounting    HTML     83K 
                Policies (Policies)                                              
36: R24         Revenue from Contracts with Customers (Tables)      HTML    575K 
37: R25         Business Combinations (Tables)                      HTML    161K 
38: R26         Fair Value Measurements and Long-term Investments   HTML    179K 
                (Tables)                                                         
39: R27         Stockholders' Equity (Tables)                       HTML    135K 
40: R28         Earnings (Loss) Per Share (Tables)                  HTML    251K 
41: R29         Goodwill and Intangible Assets (Tables)             HTML    257K 
42: R30         Debt (Tables)                                       HTML    309K 
43: R31         Income Taxes (Tables)                               HTML     60K 
44: R32         Derivative Financial Instruments (Tables)           HTML    211K 
45: R33         Other Comprehensive Income (Tables)                 HTML    366K 
46: R34         Discontinued Operations (Tables)                    HTML    140K 
47: R35         Business Segments (Tables)                          HTML    188K 
48: R36         Supplemental Disclosures (Tables)                   HTML     79K 
49: R37         Basis of Presentation and Significant Accounting    HTML     38K 
                Policies - Additional Information (Detail)                       
50: R38         Revenue from Contracts with Customers - Additional  HTML     84K 
                Information (Detail)                                             
51: R39         Revenue from Contracts with Customers - Impact of   HTML     66K 
                Adoption on Previously Reported Condensed                        
                Consolidated Balance Sheet (Detail)                              
52: R40         Revenue from Contracts with Customers - Schedule    HTML     67K 
                of Comparison Between Reported Statements to                     
                Pro-forma Amounts in Effect of Previous Guidance -               
                Consolidated Balance Sheet (Detail)                              
53: R41         Revenue from Contracts with Customers - Schedule    HTML     78K 
                of Comparison Between Reported Statements to                     
                Pro-forma Amounts in Effect of Previous Guidance -               
                Statement of Operations (Detail)                                 
54: R42         Revenue from Contract with Customer - Summary of    HTML     43K 
                Revenue Regognized Related to Various Performance                
                Obligations and Elected accounting Expedients                    
                (Detail)                                                         
55: R43         Revenue from Contracts with Customers - Summary of  HTML     71K 
                Revenue by Type and Nature of Revenue Stream by                  
                Reportable Segments (Detail)                                     
56: R44         Business Combinations - Agreement to Acquire        HTML     60K 
                Health Grid - Additional Information (Detail)                    
57: R45         Schedule of Consideration Transaction (Detail)      HTML     54K 
58: R46         Assets Acquired and Liabilities Assumed (Detail)    HTML     72K 
59: R47         Acquired Intangible Assets Amortization (Detail)    HTML     56K 
60: R48         Business Combinations - Acquisition of Practice     HTML     50K 
                Fusion, Inc - Additional Information (Detail)                    
61: R49         Business Combinations - Other Acquisitions and      HTML    120K 
                Divestiture - Additional Information (Detail)                    
62: R50         Business Combinations - Acquisition of DeVero -     HTML     40K 
                Additional Information (Detail)                                  
63: R51         Business Combinations - Acquisition of the          HTML     39K 
                Patient/Provider Engagement Solutions Business                   
                from NantHealth, Inc. - Additional Information                   
                (Detail)                                                         
64: R52         Business Combinations and Other Investments -       HTML     54K 
                Acquisition of the Enterprise Information                        
                Solutions Business from McKesson Corporation -                   
                Additional Information (Detail)                                  
65: R53         Business Combinations - Formation of Joint          HTML     42K 
                Business Entity and Acquisition of Netsmart, Inc -               
                Additional Information (Detail)                                  
66: R54         Pro forma Results (Detail)                          HTML     38K 
67: R55         Fair Value Measurements and Long-term Investments   HTML     45K 
                - Additional Information (Detail)                                
68: R56         Summary of Financial Assets and Liabilities         HTML     72K 
                Measured at Fair Value on Recurring Basis (Detail)               
69: R57         Summary of Changes in Assets and Liabilities        HTML     40K 
                Measured at Fair Value on Recurring Basis (Detail)               
70: R58         Summary of Long-term Equity Investments Included    HTML     51K 
                in Other Assets (Detail)                                         
71: R59         Stockholders' Equity - Additional Information       HTML     64K 
                (Detail)                                                         
72: R60         Stock-Based Compensation Expense (Benefit)          HTML     47K 
                (Detail)                                                         
73: R61         Stock-Based Awards Granted (Detail)                 HTML     44K 
74: R62         Calculations of Earnings (Loss) Per Share (Detail)  HTML     95K 
75: R63         Anti-Dilutive Stock Options, Restricted Stock Unit  HTML     34K 
                Awards and Warrants Excluded from Computation of                 
                Diluted Earnings (Loss) Per Share (Detail)                       
76: R64         Goodwill and Intangible Assets (Detail)             HTML     50K 
77: R65         Changes in Carrying Amount of Goodwill (Detail)     HTML     84K 
78: R66         Goodwill and Intangible Assets - Additional         HTML     64K 
                Information (Detail)                                             
79: R67         Debt Outstanding Excluding Capital Leases (Detail)  HTML     66K 
80: R68         Interest Expense (Detail)                           HTML     46K 
81: R69         Interest Expense Related to 1.25% Notes (Detail)    HTML     39K 
82: R70         Debt - Additional Information (Detail)              HTML    138K 
83: R71         Summary of Future Debt Payment Obligations          HTML     78K 
                (Detail)                                                         
84: R72         Summary of Future Debt Payment Obligations          HTML     34K 
                (Parenthetical) (Detail)                                         
85: R73         Effective Tax Rates (Detail)                        HTML     40K 
86: R74         Income Taxes - Additional Information (Detail)      HTML     65K 
87: R75         Fair Value and Balance Sheet Locations - (Detail)   HTML     53K 
88: R76         Derivative Financial Instruments - Additional       HTML     67K 
                Information (Detail)                                             
89: R77         Derivatives Instruments Designated as Cash Flow     HTML     46K 
                Hedges - (Detail)                                                
90: R78         Net Impact of Changes in Fair Value of Call Option  HTML     39K 
                and Embedded Cash Conversion Option - (Detail)                   
91: R79         Components of Accumulated Other Comprehensive Loss  HTML     61K 
                (Detail)                                                         
92: R80         Components of Accumulated Other Comprehensive Loss  HTML     38K 
                (Parenthetical) (Detail)                                         
93: R81         Income Tax Effects Related to Components of Other   HTML    115K 
                Comprehensive Income (Loss) (Detail)                             
94: R82         Income Tax Effects Related to Components of Other   HTML     34K 
                Comprehensive Income (Loss) (Parenthetical)                      
                (Detail)                                                         
95: R83         Contingencies - Additional Information (Detail)     HTML     32K 
96: R84         Discontinued Operations - Additional Information    HTML     40K 
                (Detail)                                                         
97: R85         Summary of Major Classes of Assets and Liabilities  HTML     66K 
                of Discontinued Operations (Detail)                              
98: R86         Summary of Major Classes of Line Items              HTML     69K 
                Constituting Income (Loss) of Discontinued                       
                Operations (Detail)                                              
99: R87         Business Segments - Additional Information          HTML     44K 
                (Detail)                                                         
100: R88         Revenues and Income from Operations Related to      HTML     55K  
                Segment Within Reconciliation to Consolidated                    
                Amounts (Detail)                                                 
101: R89         Supplemental Disclosures - Additional Information   HTML     40K  
                (Detail)                                                         
102: R90         Supplemental Disclosures (Detail)                   HTML     55K  
103: R91         Subsequent Events - Additional Information          HTML     51K  
                (Detail)                                                         
105: XML         IDEA XML File -- Filing Summary                      XML    202K  
104: EXCEL       IDEA Workbook of Financial Reports                  XLSX    129K  
 7: EX-101.INS  XBRL Instance -- mdrx-20180630                       XML   7.02M 
 9: EX-101.CAL  XBRL Calculations -- mdrx-20180630_cal               XML    316K 
10: EX-101.DEF  XBRL Definitions -- mdrx-20180630_def                XML   1.01M 
11: EX-101.LAB  XBRL Labels -- mdrx-20180630_lab                     XML   1.55M 
12: EX-101.PRE  XBRL Presentations -- mdrx-20180630_pre              XML   1.48M 
 8: EX-101.SCH  XBRL Schema -- mdrx-20180630                         XSD    243K 
106: ZIP         XBRL Zipped Folder -- 0001564590-18-019295-xbrl      Zip    310K  


‘ZIP’   —   XBRL Zipped Folder — 0001564590-18-019295-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:mdrx-20180630.xml
mdrx-20180630.xsd
mdrx-20180630_cal.xml
mdrx-20180630_def.xml
mdrx-20180630_lab.xml
mdrx-20180630_pre.xml


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/22  Veradigm Inc.                     10-K/A     12/31/21   12:4M                                     Donnelley … Solutions/FA
 2/25/22  Veradigm Inc.                     10-K       12/31/21  150:28M                                    Donnelley … Solutions/FA
 2/26/21  Veradigm Inc.                     10-K       12/31/20  165:35M                                    ActiveDisclosure/FA
Top
Filing Submission 0001564590-18-019295   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 9:25:41.2am ET